OrbiMed Capital GP VIII LLC, Director at Sionna Therapeutics, Inc. (SION), sold 30,953 shares at $44.57 ($1.4M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $1.4M SION by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.57 | 1,890 | $84K | 6.1% |
| 2 | $44.58 | 29,063 | $1.3M | 93.9% |
| Total | $44.58 avg | 30,953 | $1.4M | 100% |
| Filing → |
| SION | BUY | 2025-02-10 | $9.9M | — | Filing → |